CN Patent

CN121202886A — 杂环类化合物及其用途

Assigned to Yang Sheng Tang Co Ltd · Expires 2025-12-26 · 0y expired

What this patent protects

本发明涉及生物医药领域，具体涉及式(I)所示的杂环类化合物及其应用，

USPTO Abstract

本发明涉及生物医药领域，具体涉及式(I)所示的杂环类化合物及其应用，

Drugs covered by this patent

Orgovyx (relugolix) · MYOVANT SCIENCES

Patent Metadata

Patent number: CN121202886A
Jurisdiction: CN
Classification: —
Expires: 2025-12-26
Drug substance claim: No
Drug product claim: No
Assignee: Yang Sheng Tang Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.